APOE/TOMM40 genetic loci, white matter hyperintensities, and cerebral microbleeds

Donald M Lyall1,2,3,4, Susana Muñoz Maniega1,2,5, Sarah E Harris1,4

  • 1Centre for Cognitive Ageing and Cognitive Epidemiology, University of Edinburgh, Edinburgh, UK.

Abstract

Insights

This study found no link between Alzheimer's disease (AD) gene variants APOE ε and TOMM40 and markers of small vessel disease in older adults. Further research is needed to understand these complex relationships.

Area of Science:

  • Neuroscience
  • Genetics
  • Gerontology

Background:

  • Cerebral small vessel disease (CSVD) markers like white matter hyperintensities and cerebral microbleeds are common in Alzheimer's disease (AD).
  • Investigating genetic factors associated with AD susceptibility is crucial for understanding disease mechanisms.

Purpose of the Study:

  • To examine the independent associations of two AD-susceptibility gene loci, APOE ε and TOMM40 '523' poly-T repeat, with CSVD markers.
  • To assess white matter hyperintensities and cerebral microbleed burden in community-dwelling older adults.

Main Methods:

  • Genotyping for APOE ε and TOMM40 '523' was performed on 624 participants from the Lothian Birth Cohort 1936.
  • Detailed structural brain magnetic resonance imaging was conducted at a mean age of 72.7 years.

Main Results:

  • No significant associations were found between APOE ε or TOMM40 '523' genotypes and white matter hyperintensities.
  • Similarly, no significant effects were observed for cerebral microbleed burden in relation to these gene loci.

Conclusions:

  • The lack of association suggests that these specific AD susceptibility genes may not directly influence CSVD markers in this relatively healthy cohort.
  • Findings may indicate that the health status of the studied population influences the observed genetic associations compared to other studies.